Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Swedish Orphan Biovit Ord (BIOVF)

Swedish Orphan Biovit Ord (BIOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Swedish Orphan Biovit Ord Tomtebodavagen 93 A Solna Stockholm V7 SE-112 76 SWE

www.sobi.com Employees: 1,937 P: 46-8697-2000

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Swedish Orphan Biovitrum is a biotechnology company. It develops, manufactures and sells medications within hemophilia, autoimmune diseases, metabolic diseases and cancer supportive care. The Company's product portfolio consists of Core Products segment which offers pharmaceuticals within Inflammation area and Genetics and metabolic therapeutic area; Partner Products segment which offers pharmaceuticals within hematology, oncology and emergency medicines, and the ReFacto Manufacturing segment. The company operates primarily in Sweden, Denmark, Finland, Norway, United Kingdom and France. Swedish Orphan Biovitrum is based in Solna, Sweden.

Key Statistics

Overview:

Market Capitalization, $K 13,172,000
Enterprise Value, $K 14,609,260
Shares Outstanding, K 356,000
Float, K 356,000
% Float 100.00%
Short Interest, K 352
Short Float 0.10%
Days to Cover 999.99
Short Volume Ratio 1.00
% of Institutional Shareholders 0.00%

Financials:

Annual Sales, $ 2,886 M
Annual Net Income, $ 48,860 K
Last Quarter Sales, $ 817,260 K
Last Quarter Net Income, $ -304,160 K
EBIT, $ -20,710 K
EBITDA, $ 327,320 K

Growth:

1-Year Return 30.74%
3-Year Return 138.71%
5-Year Return 0.00%
5-Year Revenue Growth 63.33%
5-Year Earnings Growth -12.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.64 on 10/20/25
Next Earnings Date 05/05/26
Earnings Per Share ttm 1.51
EPS Growth vs. Prev Qtr -6.25%
EPS Growth vs. Prev Year 62.16%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

BIOVF Ratios

Ratio
Price/Earnings ttm 24.23
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 13.66%
Return-on-Assets % 7.50%
Profit Margin % 1.69%
Debt/Equity 0.37
Price/Sales 4.78
Price/Cash Flow 18.04
Price/Book 3.48
Book Value/Share 10.62
Interest Coverage 4.38
60-Month Beta 0.37
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar